HC Wainwright & Co. Downgrades Kazia Therapeutics to Neutral

HC Wainwright & Co. analyst Sean Lee downgrades Kazia Therapeutics (NASDAQ:KZIA) from Buy to Neutral.

HC Wainwright & Co. analyst Sean Lee downgrades Kazia Therapeutics (NASDAQ:KZIA) from Buy to Neutral.

Total
0
Shares
Related Posts